Archive

Alantra ranks within top 10 M&A financial advisors in Europe in Q1 2016

31 March

  March 2016. Alantra (previously N+1) emerged as the 10th M&A financial advisor in Europe by transaction value and 23rd by number of deals in the first quarter of the present year, according to Mergermarket. In this period, Alantra has advised in ten M&A transactions with an aggregated value of over US$47bn.

Alantra ranks within top 10 M&A financial advisors in Europe in Q1 2016

31 March

  March 2016. Alantra (previously N+1) emerged as the 10th M&A financial advisor in Europe by transaction value and 23rd by number of deals in the first quarter of the present year, according to Mergermarket. In this period, Alantra has advised in ten M&A transactions with an aggregated value of over US$47bn.

Case study: advisors to Ibercaja on the disposal of two loan portfolios of over €900mn

27 March

Project Goya Project Nayim Type of portfolio: Developer loans Size: €700mn Buyer: Oaktree Alantra’s role: Financial advisor Type of portfolio: NPL (Unsecured) Size €210mn Buyer: Seer Capital Alantra’s role: Financial advisor Transaction background Alantra advised Ibercaja on its effort to recapitalise by selling two portfolios with loans of €910mn on aggregate: ▸ Sale of a c.€700mn developer loan book with […]

Alantra advised Roca on the sale of a 25% stake in German Duravit

21 March

Frankfurt / Madrid– Alantra has advised Roca, leading sanitaryware and bathroom manufacturer with over 21,000 employees and 76 production facilities in 18 countries, in the sale of its 25% stake in the German sanitaryware player Duravit. Roca has maintained this stake since 1999 when it was acquired as part of the deal when Roca acquired the […]

Alantra proposes a dividend of €0.50 per share

18 March

The Company’s Board of Directors has adopted the following resolutions, among others: To authorise the separate financial statements of the Company and the consolidated financial statements of the Company and the entities comprising its group for the year ended 31 December 2015, along with the respective management reports, for issue. The consolidated financial statements show […]

Alantra advises Swiss Komax Holding on the sale of Komax Medtech to Italian IMA

14 March

Zurich- Alantra advised listed Komax Holding on the sale of Komax MedTech, an automation assembly company in the medtech space, to GIMA for approx. CHF 30 million (over €27mn). The Komax Group is a global technology company that focuses on markets in the automation sector. The Komax Group employs around 1,600 people worldwide and provides sales […]

Alantra advises Spanish Agrolimen on the acquisition of Italian Nova Foods

9 March

Madrid / Milan- Alantra Spanish and Italian teams advised Agrolimen on the acquisition of a 100% stake in Nova Foods, Italian premium pet food manufacturer owned by the Fancon Family. Nova Foods is the leading company for natural pet food products for the specialist channel with its Trainer brand. In 2015, the Company achieved sales of […]

Alantra acts as Fairness Opinion provider to Syngenta’s Board on ChemChina’s US$43bn public tender

8 March

Zurich– On 3 February 2016 Syngenta announced that ChemChina has offered to acquire 100% of the outstanding share capital of Syngenta at a price of US$465 per ordinary share plus a special dividend of CHF 5 to be paid conditional upon, and prior to, closing. The intended offer values Syngenta’s total outstanding share capital at around […]